Items where authors include "Shams, K."

Number of items: 7.

Article

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Harrison, S.R. orcid.org/0000-0002-7465-2621, Campbell, F., Bennett, H. et al. (10 more authors) (2024) High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study. British Journal of Dermatology. ljae292. ISSN 0007-0963

Kamal, K., Xia, E., Li, S.J. et al. (21 more authors) (2024) Eligibility Criteria for Active Ulcerative Pyoderma Gangrenosum in Clinical Trials: A Delphi Consensus on Behalf of the UPGRADE (Understanding Pyoderma Gangrenosum: Review and Assessment of Disease Effects) Group. Journal of Investigative Dermatology, 144 (6). 1295-1300.e6. ISSN 0022-202X

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Proceedings Paper

Campbell, F., Harrison, S., Golenya, R. et al. (10 more authors) (2024) O12 Community Psoriasis: Phenotype and Comorbidity Assessment (COPPACA): an observational study of the prevalence, phenotype and health burden of psoriasis in the community. In: British Journal of Dermatology. 104th Annual Meeting of the British Association of Dermatologists, 02-04 Jul 2024, Manchester, UK. Oxford University Press , i7-i8.

This list was generated on Thu Apr 3 04:12:11 2025 BST.